Document
IPR2017-01103, No. 1009-8 Exhibit - Ex 1009 FDA Guideline on Sterile Drug Products Produced by Aseptic Processing June 1987, reprinted June 1991 and Feb 1997 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01103, No. 1009-8 Exhibit - Ex 1009 FDA Guideline on Sterile Drug Products Produced by Aseptic Processing June 1987, reprinted June 1991 and Feb 1997 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01103, No. 2039-65 Exhibit - Exhibit 2039 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01103, No. 2039-65 Exhibit - Exhibit 2039 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01103, No. 1010-9 Exhibit - Ex 1010 EMEA Guidance on Manufacture of the Finished Dosage Form April 1996 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01103, No. 1010-9 Exhibit - Ex 1010 EMEA Guidance on Manufacture of the Finished Dosage Form April 1996 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01103, No. 2058-82 Exhibit - Exhibit 2058 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01103, No. 2058-82 Exhibit - Exhibit 2058 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01103, No. 2015-42 Exhibit - Exhibit 2015 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01103, No. 2015-42 Exhibit - Exhibit 2015 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01103, No. 2013-40 Exhibit - Exhibit 2013 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01103, No. 2013-40 Exhibit - Exhibit 2013 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01103, No. 2011-38 Exhibit - Exhibit 2011 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01103, No. 2011-38 Exhibit - Exhibit 2011 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01103, No. 2033-59 Exhibit - Exhibit 2033 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01103, No. 2033-59 Exhibit - Exhibit 2033 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01103, No. 2057-81 Exhibit - Exhibit 2057 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01103, No. 2057-81 Exhibit - Exhibit 2057 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01103, No. 1012-11 Exhibit - Ex 1012 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Sixth Day of Trial, No 06 438 GMS, Dkt 624 D Del June 9, 2008 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01103, No. 1012-11 Exhibit - Ex 1012 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Sixth Day of Trial, No 06 438 GMS, Dkt 624 D Del June 9, 2008 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01103, No. 2045-71 Exhibit - Exhibit 2045 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01103, No. 2045-71 Exhibit - Exhibit 2045 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01103, No. 1007-6 Exhibit - Ex 1007 Li et al, Fluorescein Binding to Normal Human Serum Proteins Demonstrated by Equilibrium Dialysis, Arch Ophalmol vol 100, 484 87 March 1982 (P...
Cite Document
IPR2017-01103, No. 1007-6 Exhibit - Ex 1007 Li et al, Fluorescein Binding to Normal Human Serum Proteins Demonstrated by Equilibrium Dialysis, Arch Ophalmol vol 100, 484 87 March 1982 (P.T.A.B. Apr.
+ More Snippets
Document
IPR2017-01103, No. 2019-46 Exhibit - Exhibit 2019 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01103, No. 2019-46 Exhibit - Exhibit 2019 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01103, No. 1018-17 Exhibit - Ex 1018 Ibrahim et al, Phase I and pharmacokinetic study of ABI 007, a Cremophor free, protein stabilized, nanoparticle formulation of paclitaxel, Clin Can...
Cite Document
IPR2017-01103, No. 1018-17 Exhibit - Ex 1018 Ibrahim et al, Phase I and pharmacokinetic study of ABI 007, a Cremophor free, protein stabilized, nanoparticle formulation of paclitaxel, Clin Cancer Re
+ More Snippets
Document
IPR2017-01103, No. 2016-43 Exhibit - Exhibit 2016 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01103, No. 2016-43 Exhibit - Exhibit 2016 (P.T.A.B. Jul. 12, 2017)
+ More Snippets